Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""liver"" wg kryterium: Temat

  Lista filtrów

Ogranicz do:

Wyrównaj
Wyświetlanie 1-20 z 4312
Tytuł:
[Application of liver venous deprivation in secondary hepatic resection of primary liver cancer].
Autorzy:
Shen YH; Department of Oncological Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China.
Yue AM; Department of Oncological Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China.
Ju AD; Department of Oncological Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China.
Guo JQ; Department of Oncological Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China.
Li RH; Department of Oncological Surgery, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China.
Li SX; Department of Intervention, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China.
Wang X; Department of Ultrasonography, Xinxiang Central Hospital, the Fourth Clinical College of Xinxiang Medical College, Xinxiang 453000, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2022 Nov 23; Vol. 44 (11), pp. 1221-1228.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Liver Neoplasms*/surgery
Embolization, Therapeutic*/methods
Humans ; Portal Vein ; Retrospective Studies ; Hepatectomy/methods ; Liver/surgery ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Ultrasound-guided percutaneous thermal ablation assisted by artificial ascites and soft tissue edema in the treatment of special-region hepatic tumors].
Autorzy:
Feng L; Department of Ultrasound, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang Y; Department of Ultrasound, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Niu LJ; Department of Ultrasound, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Feb 23; Vol. 46 (2), pp. 155-160.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Catheter Ablation*/methods
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Liver Neoplasms*/etiology
Carcinoma, Hepatocellular*/pathology
Humans ; Ascites/etiology ; Retrospective Studies ; Ultrasonography, Interventional ; Water ; Edema/etiology ; Edema/surgery ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
Autorzy:
Li ZM; Zhongshan Cancer Institute, Zhongshan People's Hospital, Zhongshan 528400, China.
Liang ZH; Zhongshan Cancer Institute, Zhongshan People's Hospital, Zhongshan 528400, China.
Liu N; Zhongshan Cancer Institute, Zhongshan People's Hospital, Zhongshan 528400, China.
Wei KR; Zhongshan Cancer Institute, Zhongshan People's Hospital, Zhongshan 528400, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Mar 23; Vol. 46 (3), pp. 232-238.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Nasopharyngeal Neoplasms*
Uterine Neoplasms*
Uterine Cervical Neoplasms*
Liver Neoplasms*
Lung Neoplasms*/epidemiology
Humans ; Male ; Female ; Nasopharyngeal Carcinoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Cancer incidence and mortality in China, 2022].
Autorzy:
Zheng RS; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Chen R; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Han BF; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang SM; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Li L; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Sun KX; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zeng HM; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wei WW; Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
He J; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Mar 23; Vol. 46 (3), pp. 221-231.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Liver Neoplasms*
Lung Neoplasms*
Colorectal Neoplasms*
Male ; Humans ; Female ; Incidence ; Urban Population ; Rural Population ; China/epidemiology ; Registries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[The clinical value of heat shock protein 90α in predicting the prognosis of interventional therapy for hepatocellular carcinoma].
Autorzy:
Sun W; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Li X; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Feb 23; Vol. 46 (2), pp. 118-126.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Chemoembolization, Therapeutic*/adverse effects
Humans ; Retrospective Studies ; Prognosis ; Treatment Outcome ; Neoplasm Staging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Survival analysis of malignant tumors in cancer registration areas of Hubei province in China, 2013 to 2015].
Autorzy:
Yao S; Hubei Cancer Registration Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China.
Xiong B; Wufeng Tujia Autonomous County Center for Disease Control and Prevention, Yichang 443413, China.
Tuo JY; Hubei Cancer Registration Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China.
Qin Y; Hubei Cancer Registration Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China.
Meng FD; Hubei Cancer Registration Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China.
Xia YF; Hubei Cancer Registration Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China.
Zhang M; Hubei Cancer Registration Center, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China.
Wei SZ; Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Colorectal Cancer Clinical Medical Research Center, Wuhan Colorectal Cancer Clinical Medical Research Center, Wuhan 430079, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Dec 23; Vol. 45 (12), pp. 1051-1056.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Liver Neoplasms*
Uterine Cervical Neoplasms*/epidemiology
Lung Neoplasms*
Humans ; Female ; Male ; China/epidemiology ; Urban Population ; Incidence ; Survival Analysis ; Rural Population ; Registries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Lenvatinib down-regulates IGF1R/Mek/Erk signaling pathway in the treatment of regorafenib-resistant hepatocellular carcinoma].
Autorzy:
Zhang J; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Kuang SW; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Huang N; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhang JJ; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Liu M; Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang LM; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Jun 23; Vol. 45 (6), pp. 490-498.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Animals ; Mice ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; Signal Transduction ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[The expression and function of PD-L1 in CD133(+) human liver cancer stem-like cells].
Autorzy:
Bai YD; Medical College, Southwest Jiaotong University, Chengdu 611756, China.
Shi ML; Clinical Medical College, Southwest Medical University, Luzhou 646000, China.
Li SQ; Clinical Medical College, Southwest Medical University, Luzhou 646000, China.
Wang XL; Department of Cancer, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Peng JJ; Department of Oncology, the General Hospital of Western Theater Command PLA, Chengdu 610083, China.
Zhou DJ; Department of Oncology, the General Hospital of Western Theater Command PLA, Chengdu 610083, China.
Sun FF; Department of Oncology, the General Hospital of Western Theater Command PLA, Chengdu 610083, China.
Li H; Department of Oncology, the General Hospital of Western Theater Command PLA, Chengdu 610083, China.
Wang C; Department of Pathology, the General Hospital of Western Theater Command PLA, Chengdu 610083, China.
Du M; Department of Oncology, the General Hospital of Western Theater Command PLA, Chengdu 610083, China.
Zhang T; Department of Oncology, the General Hospital of Western Theater Command PLA, Chengdu 610083, China.
Li D; Department of Oncology, the General Hospital of Western Theater Command PLA, Chengdu 610083, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Feb 23; Vol. 45 (2), pp. 117-128.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Proto-Oncogene Proteins c-akt*/metabolism
Liver Neoplasms*/pathology
Humans ; Animals ; Mice ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Ligands ; RNA, Small Interfering/metabolism ; Neoplastic Stem Cells/physiology ; Cell Line, Tumor ; Cell Proliferation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Clinical application of LDLT after reconstruction of IVC using artificial blood vessel in the treatment of HCC beyond Milan Criteria].
Autorzy:
Sun BC; Liver Transplantation Center, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China (Currently address: Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China).
Li GQ; Liver Transplantation Center, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Huang XL; Liver Transplantation Center, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Qin JJ; Liver Transplantation Center, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Mu XX; Liver Transplantation Center, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 Mar 23; Vol. 40 (3), pp. 211-215.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Vessel Prosthesis*
Liver Transplantation*
Carcinoma, Hepatocellular/*surgery
Liver Neoplasms/*surgery
Vena Cava, Inferior/*surgery
Humans ; Liver/blood supply ; Living Donors ; Retrospective Studies ; Stents ; Tissue and Organ Harvesting/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
miR-144-3p 参与高蛋氨酸饮食诱导 Cbs 小鼠的肝细胞自噬.
Autorzy:
盛思琪
谢 琳
赵翔宇
姜怡邓
吴 凯
熊建团
杨安宁
郝银菊
焦 运
Pokaż więcej
Alternatywny tytuł:
Involvement of miR-144-3p in Cbs+/- mouse hepatocyte autophagy induced by high-methionine diet.
Źródło:
Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu. 3/18/2024, Vol. 28 Issue 8, p1289-1294. 6p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Clinical analysis of liver dysfunction induced by SHR-1210 alone or combined with apatinib and chemotherapy in patients with advanced esophageal squamous cell carcinoma].
Autorzy:
Qi L; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhang B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Liu Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Mu L; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Li Q; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang X; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Xu JP; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang XY; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Huang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Mar 23; Vol. 45 (3), pp. 259-264.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/pathology
Liver Diseases*/etiology
Humans ; Prospective Studies ; Programmed Cell Death 1 Receptor/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Retrospectively analysis of characteristics and risk factors of immune treatment-related hepatic adverse events in malignant tumor].
Autorzy:
Li SL; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.
Gao XP; Department of Medical Oncology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518000, China.
Chen QQ; Department of Medical Oncology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518000, China.
Fu XH; Department of Medical Oncology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518000, China.
Zhao Y; Department of Medical Oncology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518000, China.
Duan JM; Department of Medical Oncology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518000, China.
Tang YQ; Department of Medical Oncology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518000, China.
Sun J; Department of Medical Oncology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518000, China.
Li JL; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhou QM; Department of Medical Oncology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518000, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Jan 23; Vol. 42 (1), pp. 50-54.
Typ publikacji:
Journal Article
MeSH Terms:
Immunotherapy*/adverse effects
Liver Diseases*/etiology
Neoplasms*/therapy
Female ; Humans ; Liver ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Effect evaluation of the primary screening strategy for liver cancer in rural areas of China].
Autorzy:
Cao MM; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Li H; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zha ZQ; Institute of Chronic Non-communicable Diseases Prevention and Control, Anhui Provincial Center for Disease Control and Prevention, Hefei 230601, China.
Zhou JY; Department for Chronic Non-communicable Diseases Control, Jiangsu Provincial Center for Disease Control and Prevention/Public Health Research Institute of Jiangsu Province, Nanjing 210009, China.
Luo PF; Department for Chronic Non-communicable Diseases Control, Jiangsu Provincial Center for Disease Control and Prevention/Public Health Research Institute of Jiangsu Province, Nanjing 210009, China.
Gong JY; Department of Preventive Management, Shandong Cancer Hospital and Institute/Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Ma HM; Department of Preventive Management, Shandong Cancer Hospital and Institute/Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Sun XB; Department of Disease Prevention, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450046, China.
Chen WQ; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2022 Sep 23; Vol. 44 (9), pp. 990-996.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Surface Antigens*
Liver Neoplasms*/diagnosis
Liver Neoplasms*/epidemiology
China/epidemiology ; Early Detection of Cancer ; Female ; Humans ; Incidence ; Male ; Mass Screening ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 4312

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies